FABRY Disease Registry
The Rare Disease Registry Program (including but not limited to, Gaucher, Fabry, MPS I, and Pompe diseases) is a multi-center, international, longitudinal, observational program that tracks the natural history and outcomes of patients with these rare diseases.
- Sex: Any
- Age: Child (Birth - 17), Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Registry
- Trial Phase: NA
- Conditions Being Studied: Fabry Disease
Study Purpose
Fabry disease is a rare X-linked lysosomal storage disorder that results from mutations in the gene encoding the lysosomal hydrolase, a-galactosidase A (aGAL). This is a research study that collects medical information on people with Fabry disease around the world.
Who Can Participate
All Ages
Locations
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106
- UH IRB: STUDY20200704
- StudyID: 2021-0538
- ClinicalTrials.gov: NCT00196742
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422